Free Trial

Ambev S.A. (NYSE:ABEV) Declares -- Dividend of $0.02

Ambev logo with Consumer Staples background

Ambev S.A. (NYSE:ABEV - Get Free Report) announced a -- dividend on Monday, May 12th, Wall Street Journal reports. Investors of record on Monday, May 19th will be paid a dividend of 0.0219 per share on Thursday, July 17th. This represents a yield of 5%. The ex-dividend date is Monday, May 19th.

Ambev has a dividend payout ratio of 83.3% meaning its dividend is currently covered by earnings, but may not be in the future if the company's earnings decline. Equities analysts expect Ambev to earn $0.17 per share next year, which means the company should continue to be able to cover its $0.15 annual dividend with an expected future payout ratio of 88.2%.

Ambev Stock Down 1.0%

ABEV stock traded down $0.03 during trading on Monday, reaching $2.51. 15,758,200 shares of the company traded hands, compared to its average volume of 29,194,560. Ambev has a 12 month low of $1.76 and a 12 month high of $2.64. The business has a 50 day simple moving average of $2.35 and a 200 day simple moving average of $2.13. The company has a market capitalization of $39.47 billion, a price-to-earnings ratio of 13.92, a price-to-earnings-growth ratio of 5.80 and a beta of 0.80. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.89 and a current ratio of 1.20.

Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.04 earnings per share for the quarter, hitting the consensus estimate of $0.04. The business had revenue of $3.92 billion during the quarter, compared to the consensus estimate of $22.40 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. On average, equities research analysts anticipate that Ambev will post 0.18 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ABEV has been the subject of several research analyst reports. UBS Group cut Ambev from a "buy" rating to a "neutral" rating in a research note on Tuesday, April 22nd. Citigroup restated a "neutral" rating on shares of Ambev in a research note on Wednesday, January 22nd. Morgan Stanley cut Ambev from an "equal weight" rating to an "underweight" rating in a research note on Monday, April 7th. StockNews.com assumed coverage on Ambev in a research note on Wednesday, April 23rd. They issued a "buy" rating for the company. Finally, Barclays lifted their price target on Ambev from $2.00 to $2.50 and gave the company an "equal weight" rating in a research report on Monday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Ambev currently has an average rating of "Hold" and a consensus target price of $2.70.

Read Our Latest Stock Report on Ambev

Ambev Company Profile

(Get Free Report)

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Recommended Stories

Dividend History for Ambev (NYSE:ABEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ambev Right Now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines